Impact Sibutramine Therapy in Children with Hypothalamic Obesity or Obesity with Aggravating Syndromes | Zendy

Pernilla Danielsson | Zendy; Annika Janson | Zendy; Svante Norgren | Zendy; Claude Marcus | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact Sibutramine Therapy in Children with Hypothalamic Obesity or Obesity with Aggravating Syndromes

Author(s) -

Pernilla Danielsson,

Annika Janson,

Svante Norgren,

Claude Marcus

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2007-0826

Subject(s) - sibutramine , medicine , obesity , placebo , body mass index , weight loss , childhood obesity , pediatrics , overweight , alternative medicine , pathology

Behavioral treatment of children suffering from hypothalamic obesity or uncomplicated obesity in combination with syndromes that aggravate this condition has proven to be ineffective. The combination of comorbidities and severe obesity lower the quality of these children's lives drastically. The present goal was to determine whether treatment with sibutramine has a beneficial effect on such children.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research